Balance Sheet - MoonLake Immunotherapeutics (MLTX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | |
|---|---|---|---|---|---|---|
| Total cash and short-term investments | 0.39 | 0.45 | 0.51 | 0.07 | 0.01 | 0.00 |
| Accounts receivable, net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 0.00 | |||||
| Other current assets | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total current assets | 0.42 | 0.47 | 0.51 | 0.08 | 0.01 | 0.00 |
| Total non-current assets | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.12 |
| Total assets | 0.42 | 0.48 | 0.53 | 0.08 | 0.01 | 0.12 |
| Total current liabilities | 0.05 | 0.02 | 0.01 | 0.01 | 0.02 | 0.00 |
| Total non-current liabilities | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total liabilities | 0.12 | 0.02 | 0.01 | 0.01 | 0.02 | 0.00 |
| Total stockholders' equity | 0.30 | 0.45 | 0.50 | 0.05 | -0.01 | 0.11 |
| Common shares outstanding | 64 | 63 | 49 | 29 | 37 | 15 |
Show Quarterly Balance Sheet
Balance Sheet - MoonLake Immunotherapeutics (MLTX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 0.36 | 0.39 | 0.38 | 0.43 | 0.48 | 0.45 | 0.49 | 0.52 | 0.55 | 0.51 | 0.50 | 0.50 | 0.06 | 0.07 | 0.08 | 0.09 | 0.10 | 0.01 | 0.00 | 0.00 | 0.12 | 0.00 |
| Accounts receivable, net | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | |||
| Other current assets | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total current assets | 0.40 | 0.42 | 0.41 | 0.46 | 0.51 | 0.47 | 0.51 | 0.54 | 0.55 | 0.51 | 0.50 | 0.51 | 0.07 | 0.08 | 0.09 | 0.10 | 0.12 | 0.01 | 0.00 | 0.00 | 0.00 | |
| Total non-current assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.00 | 0.12 | 0.12 | 0.12 | |
| Total assets | 0.40 | 0.42 | 0.41 | 0.46 | 0.51 | 0.48 | 0.52 | 0.54 | 0.56 | 0.53 | 0.50 | 0.51 | 0.07 | 0.08 | 0.09 | 0.10 | 0.23 | 0.01 | 0.12 | 0.12 | 0.12 | |
| Total current liabilities | 0.05 | 0.05 | 0.05 | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.20 | 0.02 | 0.00 | 0.00 | 0.00 | |
| Total non-current liabilities | 0.10 | 0.07 | 0.07 | 0.07 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total liabilities | 0.15 | 0.12 | 0.12 | 0.10 | 0.10 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.21 | 0.02 | 0.01 | 0.00 | 0.00 | |
| Total stockholders' equity | 0.25 | 0.30 | 0.29 | 0.35 | 0.41 | 0.45 | 0.49 | 0.52 | 0.54 | 0.50 | 0.42 | 0.49 | 0.04 | 0.05 | 0.06 | 0.06 | 0.02 | -0.01 | 0.11 | 0.11 | 0.11 | |
| Common shares outstanding | 71 | 64 | 63 | 63 | 63 | 63 | 63 | 63 | 63 | 60 | 54 | 44 | 39 | 39 | 37 | 35 | 37 | 37 | 37 | 37 | 15 | 15 |